CEFLAS JUNIOR (Dry Syrup)

Break the resistance of multiple infections 

CEFPODOXIME PROXETIL & POTASSIUM CLAVULANATE OREL SUSPENTION (50mg/31.25mg)

• Achieves steady state with very first dose.
• Offers clinical efficacy similar to injectables.
• Maintains concentration above MIC throughout 24Hours unlike cefixime & cefpodoxime

• Eliminates S. aureus completely.  

  Indications:

• Upper respiratory tract infections.
• Community acquired Pneumonia.
• Pharyngitis, Tonsilitis and Influnza.
• Chronic Bronchitis.